Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Behçet’s disease (BD) is a chronic inflammatory immune-mediated disease involving multiorgan systems. Gastrointes tinal (GI) manifestations of BD include abdominal pain, vomiting, GI bleeding, fistula formation, obstruction, and perforation that might require surgery. Recently, anti-tumor necrosis factor-alpha (anti-TNF-α) therapy has been shown to have favorable out comes in patients with intestinal BD who are refractory to conventional therapy. This study sought to figure out the risk factors for undergoing surgery during anti-TNF-α therapy in patients with intestinal BD. Materials and Methods: In this retrospective analysis of intestinal BD patients who were treated with anti-TNF-α, we collected the baseline patient data including comorbidities, clinical, endoscopic, and radiologic characteristics, and the Disease Activity Index for Intestinal Behçet’s Disease at the time of anti-TNF-α initiation. Each potential risk factor was compared. For multivariate analy sis, Cox regression was used. Results: A total of 62 patients were considered eligible for analysis, and 15 of them (24.1%) underwent surgery. In univariate anal ysis, the presence of extraintestinal manifestation, such as joint symptoms and erythrocyte sedimentation rate (ESR), were signifi cantly associated with surgery during therapy. In multivariate analysis, drug response within 4 weeks [hazard ratio (HR), 64.59], skin and joint manifestation (HR, 10.23 and HR, 6.22), geographic ulcer (HR, 743.97), and ESR >42.5 mm/h (HR, 9.16) were found to be factors predictive of undergoing surgery during anti-TNF-α therapy. Conclusion: We found five risk factors predictive of surgery in patients with intestinal BD receiving anti-TNF-α therapy, which can guide physicians in selecting appropriate patients between anti-TNF-α therapy and early surgery.
Abstract
Purpose: Behçet’s disease (BD) is a chronic inflammatory immune-mediated disease involving multiorgan systems. Gastrointes tinal (GI) manifestations of BD include abdominal pain, vomiting, GI bleeding, fistula formation, obstruction, and perforation that might require surgery. Recently, anti-tumor necrosis factor-alpha (anti-TNF-α) therapy has been shown to have favorable out comes in patients with intestinal BD who are refractory to conventional therapy. This study sought to figure out the risk factors for undergoing surgery during anti-TNF-α therapy in patients with intestinal BD. Materials and Methods: In this retrospective analysis of intestinal BD patients who were treated with anti-TNF-α, we collected the baseline patient data including comorbidities, clinical, endoscopic, and radiologic characteristics, and the Disease Activity Index for Intestinal Behçet’s Disease at the time of anti-TNF-α initiation. Each potential risk factor was compared. For multivariate analy sis, Cox regression was used. Results: A total of 62 patients were considered eligible for analysis, and 15 of them (24.1%) underwent surgery. In univariate anal ysis, the presence of extraintestinal manifestation, such as joint symptoms and erythrocyte sedimentation rate (ESR), were signifi cantly associated with surgery during therapy. In multivariate analysis, drug response within 4 weeks [hazard ratio (HR), 64.59], skin and joint manifestation (HR, 10.23 and HR, 6.22), geographic ulcer (HR, 743.97), and ESR >42.5 mm/h (HR, 9.16) were found to be factors predictive of undergoing surgery during anti-TNF-α therapy. Conclusion: We found five risk factors predictive of surgery in patients with intestinal BD receiving anti-TNF-α therapy, which can guide physicians in selecting appropriate patients between anti-TNF-α therapy and early surgery.
참고문헌 (30)
- Skef W, "Gastrointestinal Behçet’s disease : a review", World J Gastroenterol, 21, pp.3801~3812 (2015)
- Sakane T, "Behçet’s disease", N Engl J Med, 341, pp.1284~1291 (1999)
- Jung HC, "Temporal changes in the clinical type or diagnosis of Behçet’s colitis in patients with aphthoid or punched-out colonic ulcerations", J Korean Med Sci, 6, pp.313~318 (1991)
- Cha HJ, "Concurrent gastric adenocarcinoma of fundic gland type and carcinoma with lymphoid stroma : a rare case report", Case Rep Gastroenterol, 10, pp.292~301 (2016)
- Watanabe K, "Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants", J Gastroenterol, 55, pp.679~700 (2020)
- 천재희, "Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists", 대한류마티스학회지, 28(1), pp.4~16 (2021), 대한류마티스학회[DOI]
- Kobayashi K, "Development of consensus statements for the diagnosis and management of intestinal Behçet’s disease using a modified Delphi approach", J Gastroenterol, 42, pp.737~745 (2007)
- Hisamatsu T, "The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease : indication of anti-TNFα monoclonal antibodies", J Gastroenterol, 49, pp.156~162 (2014)
- Vicente CS, "Surgical treatment of intestinal perforation in Behçet syndrome : an unusual presentation", Pan Afr Med J, 30, pp.230~ (2018)
- Jung YS, "Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease", Inflamm Bowel Dis, 17, pp.1594~1602 (2011)
- 박재준, "Outcome Predictors for Intestinal Behçet’s Disease", Yonsei Medical Journal, 54(5), pp.1084~1090 (2013), 연세대학교의과대학[DOI]
- Jung YS, "Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease", Inflamm Bowel Dis, 18, pp.1064~1071 (2012)
- Kim DK, "Clinical manifestations and course of intestinal Behet’s disease : an analysis in relation to disease subtypes", Intest Res, 3, pp.48~54 (2005)
- Mizushima Y, "Recent research into Behçet’s disease in Japan", Int J Tissue React, 10, pp.59~65 (1988)
- International Study Group for Behcet’s Disease, "Criteria for diagnosis of Behcet's disease", Lancet, 335, pp.1078~1080 (1990)
- Yasuo Suzuki, "Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study", Intestinal research, 19(3), pp.301~312 (2021), 대한장연구학회[DOI]
- Tadakazu Hisamatsu, "Treatment and outcomes: medical and surgical treatment for intestinal Behçet’s disease", Intestinal research, 15(3), pp.318~327 (2017), 대한장연구학회
- Baek SJ, "Surgical treatment and outcomes in patients with intestinal Behçet disease : long-term experience of a single large-volume center", Dis Colon Rectum, 58, pp.575~581 (2015)
- Cheon JH, "Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease", Inflamm Bowel Dis, 17, pp.605~613 (2011)
- Bayraktar Y, "Gastrointestinal manifestations of Behcet’s disease", J Clin Gastroenterol, 30, pp.144~154 (2000)
- Choi IJ, "Longterm clinical course and prognostic factors in intestinal Behçet’s disease", Dis Colon Rectum, 43, pp.692~700 (2000)
- Kim JS, "Prediction of the clinical course of Behçet’s colitis according to macroscopic classification by colonoscopy", Endoscopy, 32, pp.635~640 (2000)
- Chung MJ, "Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease", J Clin Gastroenterol, 44, pp.e116~e122 (2010)
- Miyazaki H, "Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet’s disease", BMC Gastroenterol, 22, pp.149~ (2022)
- Jung YS, "Clinical course of intestinal Behcet’s disease during the first five years", Dig Dis Sci, 58, pp.496~503 (2013)
- Moon CM, "Prediction of free bowel perforation in patients with intestinal Behçet’s disease using clinical and colonoscopic findings", Dig Dis Sci, 55, pp.2904~2911 (2010)
- Lee JH, "Efficacy of infliximab in intestinal Behçet’s disease : a Korean multicenter retrospective study", Inflamm Bowel Dis, 19, pp.1833~1838 (2013)
- Zeitz J, "Pain in IBD patients : very frequent and frequently insufficiently taken into account", PLoS One, 11, pp.e0156666~ (2016)
- 김정민, "Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases", Intestinal research, 18(3), pp.249~264 (2020), 대한장연구학회[DOI]
- Iida M, "Postoperative recurrence in patients with intestinal Behçet’s disease", Dis Colon Rectum, 37, pp.16~21 (1994)